Harraden Circle Investments, LLC 13D/13G Filings for Aspire Biopharma Holdings, Inc. (ASBP)

Harraden Circle Investments, LLC 13D and 13G filings for Aspire Biopharma Holdings, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-05-15
12:14 pm
Purchase
2025-03-31 13G Aspire Biopharma Holdings, Inc.
ASBP
Harraden Circle Investments, LLC 150,000
0.310%
150,000increase
(New Position)
Filing